AarogyaAI
Prescriptive AnalyticsAarogyaAI
Keywords:
aarogyaai, antimicrobial resistance, drug-resistant tuberculosis, Ai in healthcare, genomics, precision diagnostics, healthcare technology, machine learning in health, genomic sequencing, Ai diagnostics, drug susceptibility testing, healthtech startup
SUMMARY
AarogyaAI is a health technology company that aims to revolutionize the diagnosis and treatment of drug-resistant infections, particularly tuberculosis (TB), the company focuses on utilizing artificial intelligence (AI) and genomics to address the growing challenge of antimicrobial resistance (AMR). Their core mission is to make precision diagnosis for AMR more accessible at the point of care. AarogyaAI's innovative approach involves a diagnostic pipeline that combines next-generation sequencing with AI. This system allows for rapid and accurate drug susceptibility testing, generating patient-specific reports within 24 to 48 hours. This method is particularly crucial in the context of TB, a disease significantly impacted by the emergence of drug resistance. The company's work is based on a comprehensive database of TB samples, which powers the AI algorithms to not only detect current drug resistance but also predict future patterns. This predictive capability is essential for preemptive planning and combating potential pandemics. By bridging the gap between advanced research and practical application, AarogyaAI is at the forefront of tackling one of the most pressing public health concerns today: the rise of 'superbugs' resistant to existing antimicrobials.
PRODUCTS
AI-driven diagnostic pipeline for drug susceptibility testing, Genomic sequencing applications for detecting drug resistance
SERVICES
Precision diagnosis for antimicrobial resistance, AI and genomics-based healthcare solutions, Rapid drug resistance testing for tuberculosis
FOUNDER DETAILS
Avlokita Tiwari
AarogyaAI, expertise in computational biology and genomic data
Praapti Jayaswal
expertise in microbiology and tuberculosis research
ABOUT
AarogyaAI, founded in 2019, harnesses AI and genomics to combat antimicrobial resistance, focusing on precision diagnostics.
COMPANY TYPE
SERVICE VERTICALS
TECHNOLOGY
THERAPEUTIC AREAS
VALUE OFFERING
LOCATION
NO 677, 1ST FLOOR, SUITE NO 918, 13TH CROSS, SECTOR 1, HSR LAYOUT, BANGALORE Bangalore KA 560102 India
TARGET USERS
- HCP
INCORPORATION DATE
May 31, 2019
STATE/CITY
Karnataka, Bengaluru
INDEX DATA USAGE NOTICE
At Mocero Health, we are committed to maintaining the trust and confidence of our visitors and users. This Index Data Usage Notice explains how we collect, use, and share data related to the various indices and aggregated metrics presented on our site. Index data on Mocero Health is generated through a combination of proprietary algorithms, user interactions, and publicly available health data. This may include, but is not limited to, health condition prevalence rates, treatment effectiveness scores, healthcare facility ratings, and user search trends. If you have concerns about how your data is used or wish to exercise your rights, please contact us at +91-9500115161. By using Mocero Health, you acknowledge and agree to the collection, use, and sharing of index data as described in this notice.
CONTENT DISCLAIMER
The information provided on this website is intended for general and educational purposes only. We reserve the right to modify this content policy at any time. Changes will be effective immediately upon posting the revised policy. Your continued use of the platform after any changes signifies your agreement to the new terms. If you have concerns about how your data is used or wish to exercise your rights, please contact us at +91-9500115161. By using this site, you acknowledge and agree that you have read and understood this Content Disclaimer.
News
Stay up-to-date with news about health-tech startups, compiled and presented in a centralized platform.
